Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 147 No. 3334 (2017)

Acute aortic dissection: pathogenesis, risk factors and diagnosis

DOI
https://doi.org/10.4414/smw.2017.14489
Cite this as:
Swiss Med Wkly. 2017;147:w14489
Published
25.08.2017

Summary

Acute aortic dissection is a rare but life-threatening condition with a lethality rate of 1 to 2% per hour after onset of symptoms in untreated patients. Therefore, its prompt and proper diagnosis is vital to increase a patient’s chance of survival and to prevent grievous complications. Typical symptoms of acute aortic dissection include severe chest pain, hypotension or syncope and, hence, mimic acute myocardial infarction or pulmonary embolism. Advanced age, male gender, long-term history of arterial hypertension and the presence of aortic aneurysm confer the greatest population attributable risk. However, patients with genetic connective tissue disorders such as Marfan, Loeys Dietz or Ehlers Danlos syndrome, and patients with bicuspid aortic valves are at the increased risk of aortic dissection at a much younger age. Imaging provides a robust foundation for diagnosing acute aortic dissection, as well as for monitoring of patients at increased risk of aortic disease. As yet, easily accessible blood tests play only a small role but have the potential to make diagnosis and monitoring of patients simpler and more cost-effective.

References

  1. Clouse WD, Hallett JW, Jr, Schaff HV, Spittell PC, Rowland CM, Ilstrup DM, et al. Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc. 2004;79(2):176–80. doi:.https://doi.org/10.4065/79.2.176
  2. Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM ; Oxford Vascular Study. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127(20):2031–7. doi:.https://doi.org/10.1161/CIRCULATIONAHA.112.000483
  3. Olsson C, Thelin S, Ståhle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006;114(24):2611–8. doi:.https://doi.org/10.1161/CIRCULATIONAHA.106.630400
  4. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903. doi:.https://doi.org/10.1001/jama.283.7.897
  5. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al., The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. Eur Heart J. 2014;35(41):2873–926. doi:.https://doi.org/10.1093/eurheartj/ehu281
  6. Conway BD, Stamou SC, Kouchoukos NT, Lobdell KW, Khabbaz KR, Murphy E, et al. Improved clinical outcomes and survival following repair of acute type A aortic dissection in the current era. Interact Cardiovasc Thorac Surg. 2014;19(6):971–6. doi:.https://doi.org/10.1093/icvts/ivu268
  7. Trimarchi S, Nienaber CA, Rampoldi V, Myrmel T, Suzuki T, Mehta RH, et al.; International Registry of Acute Aortic Dissection Investigators. Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience. J Thorac Cardiovasc Surg. 2005;129(1):112–22. doi:.https://doi.org/10.1016/j.jtcvs.2004.09.005
  8. Schoenrath F, Laber R, Maralushaj M, Henzi D, Caliskan EI, Seifert B, et al. Survival, Neurologic Injury, and Kidney Function after Surgery for Acute Type A Aortic Dissection. Thorac Cardiovasc Surg. 2016;64(2):100–7.
  9. Vilacosta I, Aragoncillo P, Cañadas V, San Román JA, Ferreirós J, Rodríguez E. Acute aortic syndrome: a new look at an old conundrum. Postgrad Med J. 2010;86(1011):52–61. doi:.https://doi.org/10.1136/hrt.2008.153650
  10. White A, Broder J, Mando-Vandrick J, Wendell J, Crowe J. Acute aortic emergencies--part 2: aortic dissections. Adv Emerg Nurs J. 2013;35(1):28–52. doi:.https://doi.org/10.1097/TME.0b013e31827145d0
  11. Ishii T, Asuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol. 2000;31(6):640–6. doi:.https://doi.org/10.1053/hupa.2000.7642
  12. Del Porto F, di Gioia C, Tritapepe L, Ferri L, Leopizzi M, Nofroni I, et al. The multitasking role of macrophages in Stanford type A acute aortic dissection. Cardiology. 2014;127(2):123–9. doi:.https://doi.org/10.1159/000355253
  13. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998;102(11):1900–10. doi:.https://doi.org/10.1172/JCI2182
  14. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg. 2004;78(6):2106–10, discussion 2110–1. doi:.https://doi.org/10.1016/j.athoracsur.2004.05.088
  15. Ikonomidis JS, Jones JA, Barbour JR, Stroud RE, Clark LL, Kaplan BS, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation. 2006;114(1, Suppl):I365–70.
  16. Manabe T, Imoto K, Uchida K, Doi C, Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection. Surg Today. 2004;34(3):220–5. doi:.https://doi.org/10.1007/s00595-003-2683-3
  17. Hahn AW, Jonas U, Bühler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett. 1994;347(2-3):178–80. doi:.https://doi.org/10.1016/0014-5793(94)00531-1
  18. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38(3):399–403. doi:.https://doi.org/10.1161/01.HYP.38.3.399
  19. Stumpf C, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, et al. Elevated VEGF-plasma levels in young patients with mild essential hypertension. Eur J Clin Invest. 2009;39(1):31–6. doi:.https://doi.org/10.1111/j.1365-2362.2008.02056.x
  20. Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, Katritsis D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol. 2002;83(1):13–21. doi:.https://doi.org/10.1016/S0167-5273(02)00021-9
  21. Derosa G, D’Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, et al. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium. 2006;13(3):227–31. doi:.https://doi.org/10.1080/10623320600780942
  22. Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, et al.; International Registry of Aortic Dissection (IRAD). Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004;43(4):665–9. doi:.https://doi.org/10.1016/j.jacc.2003.08.054
  23. Trimarchi S, Eagle KA, Nienaber CA, Rampoldi V, Jonker FH, De Vincentiis C, et al.; International Registry of Acute Aortic Dissection Investigators. Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg. 2010;140(4):784–9. doi:.https://doi.org/10.1016/j.jtcvs.2009.11.014
  24. Landenhed M, Engström G, Gottsäter A, Caulfield MP, Hedblad B, Newton-Cheh C, et al. Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. J Am Heart Assoc. 2015;4(1):e001513. doi:.https://doi.org/10.1161/JAHA.114.001513
  25. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74(5):S1877–80, discussion S1892–8. doi:.https://doi.org/10.1016/S0003-4975(02)04147-4
  26. Pape LA, Tsai TT, Isselbacher EM, Oh JK, O’gara PT, Evangelista A, et al.; International Registry of Acute Aortic Dissection (IRAD) Investigators. Aortic diameter >or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2007;116(10):1120–7. doi:.https://doi.org/10.1161/CIRCULATIONAHA.107.702720
  27. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48(12):3522–31. doi:.https://doi.org/10.1002/art.11353
  28. Gonzalez-Gay MA, Garcia-Porrua C, Piñeiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore). 2004;83(6):335–41. doi:.https://doi.org/10.1097/01.md.0000145366.40805.f8
  29. Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2009;37(2):149–59. doi:.https://doi.org/10.1016/j.ejvs.2008.11.032
  30. Homme JL, Aubry MC, Edwards WD, Bagniewski SM, Shane Pankratz V, Kral CA, et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol. 2006;30(9):1159–68. doi:.https://doi.org/10.1097/01.pas.0000213270.38091.69
  31. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res. 2001;88(1):37–43. doi:.https://doi.org/10.1161/01.RES.88.1.37
  32. Ramirez F, Sakai LY, Dietz HC, Rifkin DB. Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology. Physiol Genomics. 2004;19(2):151–4. doi:.https://doi.org/10.1152/physiolgenomics.00092.2004
  33. Détaint D, Faivre L, Collod-Beroud G, Child AH, Loeys BL, Binquet C, et al. Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J. 2010;31(18):2223–9. doi:.https://doi.org/10.1093/eurheartj/ehq258
  34. Boutouyrie P, Germain DP, Fiessinger JN, Laloux B, Perdu J, Laurent S. Increased carotid wall stress in vascular Ehlers-Danlos syndrome. Circulation. 2004;109(12):1530–5. doi:.https://doi.org/10.1161/01.CIR.0000121741.50315.C2
  35. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355(8):788–98. doi:.https://doi.org/10.1056/NEJMoa055695
  36. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900. doi:.https://doi.org/10.1016/S0735-1097(02)01886-7
  37. Fondard O, Detaint D, Iung B, Choqueux C, Adle-Biassette H, Jarraya M, et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J. 2005;26(13):1333–41. doi:.https://doi.org/10.1093/eurheartj/ehi248
  38. Fedak PW, de Sa MP, Verma S, Nili N, Kazemian P, Butany J, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg. 2003;126(3):797–805. doi:.https://doi.org/10.1016/S0022-5223(03)00398-2
  39. Andreassi MG, Della Corte A. Genetics of bicuspid aortic valve aortopathy. Curr Opin Cardiol. 2016;31(6):585–92. doi:.https://doi.org/10.1097/HCO.0000000000000328
  40. Tadros TM, Klein MD, Shapira OM. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation. 2009;119(6):880–90. doi:.https://doi.org/10.1161/CIRCULATIONAHA.108.795401
  41. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA. 2011;306(10):1104–12. doi:.https://doi.org/10.1001/jama.2011.1286
  42. Guo DC, Grove ML, Prakash SK, Eriksson P, Hostetler EM, LeMaire SA, et al.; GenTAC Investigators; BAVCon Investigators. Genetic Variants in LRP1 and ULK4 Are Associated with Acute Aortic Dissections. Am J Hum Genet. 2016;99(3):762–9. doi:.https://doi.org/10.1016/j.ajhg.2016.06.034
  43. Mészáros I, Mórocz J, Szlávi J, Schmidt J, Tornóci L, Nagy L, et al. Epidemiology and clinicopathology of aortic dissection. Chest. 2000;117(5):1271–8. doi:.https://doi.org/10.1378/chest.117.5.1271
  44. Harris KM, Strauss CE, Eagle KA, Hirsch AT, Isselbacher EM, Tsai TT, et al.; International Registry of Acute Aortic Dissection (IRAD) Investigators. Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2011;124(18):1911–8. doi:.https://doi.org/10.1161/CIRCULATIONAHA.110.006320
  45. Meredith EL, Masani ND. Echocardiography in the emergency assessment of acute aortic syndromes. Eur J Echocardiogr. 2009;10(1):i31–9. doi:.https://doi.org/10.1093/ejechocard/jen251
  46. Shiga T, Wajima Z, Apfel CC, Inoue T, Ohe Y. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med. 2006;166(13):1350–6. doi:.https://doi.org/10.1001/archinte.166.13.1350
  47. Shiga T, Wajima Z, Inoue T, Ogawa R. Survey of observer variation in transesophageal echocardiography: comparison of anesthesiology and cardiology literature. J Cardiothorac Vasc Anesth. 2003;17(4):430–42. doi:.https://doi.org/10.1016/S1053-0770(03)00146-0
  48. Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, et al.; IRAD-Bio Investigators. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation. 2009;119(20):2702–7. doi:.https://doi.org/10.1161/CIRCULATIONAHA.108.833004
  49. Shimony A, Filion KB, Mottillo S, Dourian T, Eisenberg MJ. Meta-analysis of usefulness of d-dimer to diagnose acute aortic dissection. Am J Cardiol. 2011;107(8):1227–34. doi:.https://doi.org/10.1016/j.amjcard.2010.12.027
  50. Asha SE, Miers JW. A Systematic Review and Meta-analysis of D-dimer as a Rule-out Test for Suspected Acute Aortic Dissection. Ann Emerg Med. 2015;66(4):368–78. doi:.https://doi.org/10.1016/j.annemergmed.2015.02.013
  51. Vagnarelli F, Corsini A, Bugani G, Lorenzini M, Longhi S, Bacchi Reggiani ML, et al. Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis. Eur Heart J Acute Cardiovasc Care. 2016;5(7):61–71.
  52. Vrsalovic M. Prognostic effect of cardiac troponin elevation in acute aortic dissection: A meta-analysis. Int J Cardiol. 2016;214:277–8. doi:.https://doi.org/10.1016/j.ijcard.2016.03.230
  53. del Porto F, Proietta M, Tritapepe L, Miraldi F, Koverech A, Cardelli P, et al. Inflammation and immune response in acute aortic dissection. Ann Med. 2010;42(8):622–9. doi:.https://doi.org/10.3109/07853890.2010.518156
  54. Shinohara T, Suzuki K, Okada M, Shiigai M, Shimizu M, Maehara T, et al. Soluble elastin fragments in serum are elevated in acute aortic dissection. Arterioscler Thromb Vasc Biol. 2003;23(10):1839–44. doi:.https://doi.org/10.1161/01.ATV.0000085016.02363.80
  55. Li Y, Shao AZ, Jiang HT, Dong GH, Xu B, Yi J, et al. The prominent expression of plasma matrix metalloproteinase-8 in acute thoracic aortic dissection. J Surg Res. 2010;163(2):e99–104. doi:.https://doi.org/10.1016/j.jss.2010.05.030
  56. Proietta M, Tritapepe L, Cifani N, Ferri L, Taurino M, Del Porto F. MMP-12 as a new marker of Stanford-A acute aortic dissection. Ann Med. 2014;46(1):44–8. doi:.https://doi.org/10.3109/07853890.2013.876728
  57. Suzuki T, Katoh H, Tsuchio Y, Hasegawa A, Kurabayashi M, Ohira A, et al. Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection. The smooth muscle myosin heavy chain study. Ann Intern Med. 2000;133(7):537–41. doi:.https://doi.org/10.7326/0003-4819-133-7-200010030-00013
  58. Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, et al.; International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) Investigators. Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection. Eur Heart J. 2008;29(11):1439–45. doi:.https://doi.org/10.1093/eurheartj/ehn162
  59. van der Linde D, Rossi A, Yap SC, McGhie JS, van den Bosch AE, Kirschbaum SW, et al. Ascending aortic diameters in congenital aortic stenosis: cardiac magnetic resonance versus transthoracic echocardiography. Echocardiography. 2013;30(5):497–504. doi:.https://doi.org/10.1111/echo.12086
  60. Harris KM, Strauss CE, Duval S, Unger BT, Kroshus TJ, Inampudi S, et al. Multidisciplinary standardized care for acute aortic dissection: design and initial outcomes of a regional care model. Circ Cardiovasc Qual Outcomes. 2010;3(4):424–30. doi:.https://doi.org/10.1161/CIRCOUTCOMES.109.920140